Showing 1 to 3 of 3 results


Optiscan's Gen2 Endomicroscope Launches Pre-Clinical Trial in Germany
Optiscan Imaging, an ASX-listed medtech company, launched a pre-clinical study in Germany for its second-generation flexible endomicroscope, aiming to improve gastrointestinal disease diagnosis and treatment using real-time cellular-level imaging; this collaboration with the University Medical Cente...
Optiscan's Gen2 Endomicroscope Launches Pre-Clinical Trial in Germany
Optiscan Imaging, an ASX-listed medtech company, launched a pre-clinical study in Germany for its second-generation flexible endomicroscope, aiming to improve gastrointestinal disease diagnosis and treatment using real-time cellular-level imaging; this collaboration with the University Medical Cente...
Progress
40% Bias Score


ASX Stock Surge: Sparc, Argent Biopharma Lead Market Gains
Sparc's share price soared to an 11-month high after announcing stage-two of its hydrogen JV, while Argent Biopharma jumped 64 percent following a successful US\$4.5 million capital raise; Australian Mines rose 60 percent on increased scandium resources; and Dimerix climbed 44 percent after a deal w...
ASX Stock Surge: Sparc, Argent Biopharma Lead Market Gains
Sparc's share price soared to an 11-month high after announcing stage-two of its hydrogen JV, while Argent Biopharma jumped 64 percent following a successful US\$4.5 million capital raise; Australian Mines rose 60 percent on increased scandium resources; and Dimerix climbed 44 percent after a deal w...
Progress
44% Bias Score

Liberia's Medtech Faces FIA Probe for Alleged Financial Misconduct
Medtech Scientific Liberia Limited, holding an 80% revenue share from imported goods, faces an FIA investigation for alleged financial misconduct, including overcharging customers and obstructing justice, potentially leading to administrative and criminal sanctions.

Liberia's Medtech Faces FIA Probe for Alleged Financial Misconduct
Medtech Scientific Liberia Limited, holding an 80% revenue share from imported goods, faces an FIA investigation for alleged financial misconduct, including overcharging customers and obstructing justice, potentially leading to administrative and criminal sanctions.
Progress
52% Bias Score
Showing 1 to 3 of 3 results